Arkadios Wealth Advisors Gilead Sciences, Inc. Transaction History

Arkadios Wealth Advisors

$1.64 Billion
Q3 2024

A detailed history of Arkadios Wealth Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Arkadios Wealth Advisors holds 33,983 shares of GILD stock, worth $3.19 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

33,983

Previous 38,124 10.86%

Holding current value

$3.19 Million

Previous $2.62 Million 8.91%

% of portfolio

0.17%

Previous 0.19%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$66.59 - $83.99 $275,749 - $347,802	-4,141 Reduced 10.86%	33,983 $2.85 Million
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $707,532 - $816,547	11,204 Added 41.62%	38,124 $2.62 Million
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $40,872 - $49,842	-571 Reduced 2.08%	26,920 $1.97 Million
Q4 2023 Jan 24, 2024	BUY	$73.27 - $83.09 $674,377 - $764,760	9,204 Added 50.33%	27,491 $2.23 Million
Q3 2023 Oct 13, 2023	BUY	$73.94 - $80.67 $1.07 Million - $1.17 Million	14,456 Added 377.34%	18,287 $1.37 Million
Q2 2023 Jul 26, 2023	BUY	$76.01 - $86.7 $14,897 - $16,993	196 Added 5.39%	3,831 $295,000
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $2,628 - $2,994	34 Added 0.94%	3,635 $301,000
Q4 2022 Jan 11, 2023	SELL	$62.32 - $89.47 $54,218 - $77,838	-870 Reduced 19.46%	3,601 $0
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $266,203 - $304,072	4,471 New	4,471 $276,000
Q4 2021 Feb 03, 2022	SELL	$64.88 - $73.64 $161,745 - $183,584	-2,493 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $45,758 - $49,368	676 Added 37.2%	2,493 $174,000
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $77,687 - $84,884	1,224 Added 206.41%	1,817 $125,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $4,440 - $5,066	-74 Reduced 11.09%	593 $38,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $3,965 - $4,518	-70 Reduced 9.5%	667 $38,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $69,676 - $87,605	-1,122 Reduced 60.36%	737 $45.7 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $11,502 - $13,356	159 Added 9.35%	1,859 $143 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $56,367 - $72,198	900 Added 112.5%	1,700 $127 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $49,296 - $54,224	800 New	800 $51,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Gilead Sciences, Inc. Transaction History